Dr. Goldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7777 Forest LN
Suite D 400
Dallas, TX 75230Phone+1 972-566-6647Fax+1 972-566-6496
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1993 - 1996
Children's National HospitalResidency, Pediatrics, 1990 - 1993
Boston University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1996 - Present
TX State Medical License 1998 - 2026
MD State Medical License 1993 - 1996- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Start of enrollment: 2019 Dec 27
- Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome
Roles: Principal Investigator
Publications & Presentations
PubMed
- 290 citationsA randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysisStanton Goldman, John S. Holcenberg, Jerry Z. Finklestein, Raymond J. Hutchinson, Susan G. Kreissman
Blood. 2001-05-15 - 112 citationsRituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.S. Goldman, Lynette M. Smith, James R. Anderson, Sherrie L. Perkins, Lauren Harrison
Leukemia. 2013-04-01 - 60 citationsOutcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapyMary Gerrard, I. Waxman, Richard Sposto, Anne Auperin, Sherrie L. Perkins
Blood. 2013-01-10
Journal Articles
- Overall Survival of Children and Adolescents with Mature B Cell Non‐Hodgkin Lymphoma Who Had Refractory or Relapsed Disease During or After Treatment with FAB/LMB 96: ...Mitchell Cairo, Sherrie L Perkins, Stanton Goldman, British Journal of Haematology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
